SavedAdd your journal

Journals / İnfeksiyon Dergisi / 2006 / Cilt: 20 - Sayı: 3

Ceftriaxone induced severe thrombocytopenia: A case report

Seftriaksona bağlı gelişen ciddi trombositopeni: Bir olgu sunumu

Sayın Selda KUTLU
Suzan SAÇAR
Toprak Semra KAVAS
Hırçın Derya CENGER
Hüseyin TURGUT
Pages
199–201
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, a 22-year-old female case of ceftriaxone-induced thrombocytopenia is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A variety of diseases, hereditary conditions, toxins, and drugs may cause thrombocytopenia.
📊
Key Findings & Data:Severe thrombocytopenia induced by ceftriaxone has been rarely reported.
💡
Conclusion & Impact:In this paper, a 22-year-old female case of ceftriaxone-induced thrombocytopenia is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A variety of diseases, hereditary conditions, toxins, and drugs may cause thrombocytopenia. Severe thrombocytopenia induced by ceftriaxone has been rarely reported. In this paper, a 22-year-old female case of ceftriaxone-induced thrombocytopenia is presented.

Özet

laçlar, çeşitli hastalıklar, kalıtsal bozukluklar ve toksinler trombositopeni etiyolojisinde yer almaktadır. Seftriakson ile ilişkili, ciddi trombositopeni nadir olarak görülmektedir. Bu yazıda, seftriaksona bağlı ciddi trombositopeni gelişen 22 yaşında bir kadın olgu sunulmuştur.

🔖

Cite This Article

KUTLU, S. S., SAÇAR, S., KAVAS, T. S., CENGER, H. D., TURGUT, H. (2022). Ceftriaxone induced severe thrombocytopenia: A case report. İnfeksiyon Dergisi, Cilt: 20 - Sayı: 3, 199–201. https://ajindex.com/articles/546453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Kuwana M, Okazaki Y, Satoh T, Asahi A, Kajihara M, Ikeda Y. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 1026-33
  2. Starr J A, Ragucci KR. Thrombocytopenia associated with intravenous ciprofloxacin. Pharmacotherapy 2005; 25: 1030-4
  3. Andes DR, Craig WA. Cephalosporins. In: Gerald LM, John EB, Raphael D, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 2005: 294-311
  4. Aster RH. Drug-induced immune cytopenias. Toxicology 2005; 15: 149-53
  5. Van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf 2004; 1243-52. 6.Baron BW, Besien K, Hoffman PC, Kohn BF, Rossof AF, Baron JM. Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. Transfusion 2003; 1317-21. 7.Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Transfusion 2004; 1033-40. 8.Akova M, Kayaalp SO. Beta laktam antibiyotikler II: Sefalosporinler ve diğerleri. Kayaalp SO, ed. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji de. Ankara: 2002:234-58. 9.Nomura S. Definition and mechanism of drug-induced thrombocytopenia. Rinsho Byori 2005; 617-21 10. George JN, Raskob GE, Shah SR et al. Drug-induced thrombocytopenia, A systematic review of published case Reports. Ann Intern Med 1998; 886-90.